TY  - BOOK
ED  - United States.
TI  - EpiPen price increases: how regulatory barriers inhibit pharmaceutical competition : field hearing of the Subcommittee on Children and Families of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fourteenth Congress, second session on examining EpiPen price increases, focusing on how regulatory barriers inhibit pharmaceutical competition, October 7, 2016 (Lexington, KY)
T2  - S. hrg.
AV  - KF26 .L2733 2016
PY  - 2018///
CY  - Washington
PB  - U.S. Government Publishing Office
KW  - Prescription pricing
KW  - United States
KW  - Drugs
KW  - Law and legislation
KW  - Pharmaceutical industry
KW  - Competition
KW  - Drug delivery devices
KW  - Prices
KW  - Legislative hearings
KW  - lcgft
N1  - CRDP Program record; Includes bibliographical references
UR  - https://purl.fdlp.gov/GPO/gpo113215
ER  -